Top Premarket Decliners
MT newswire2026/10/07 11:3807:38 AM EDT, 10/07/2026 (MT Newswires) -- Caribou Biosciences (CRBU) shares were down 39% in premarket activity Wednesday after the company overnight said that it was exploring strategic alternatives to maximize stockholder value and that it planned to discontinue development activities for its two allogeneic CAR-T cell therapy programs. OLB Group (OLB) stock was 31% lower pre-bell, reversing a nearly 118% gain in the previous session. Actuate Therapeutics (ACTU) shares were down 19% after the company filed a preliminary prospectus with the US Securities and Exchange Commission for a proposed offering of 50 million common shares. Delixy (DLXY) stock was 15% lower in premarket activity, reversing a 22% gain from Tuesday's session. QTREX Quantum (QTEX) shares were down 13%, after closing the previous session with a 3.3% rise.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Crypto prices
More
